Clinical Trial Update: CD19 CAR-T Therapy for Patients With Newly Diagnosed High-risk Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating CD19 CAR-T therapy in newly diagnosed high-risk Large B-cell Lymphoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large B-cell Lymphoma

Drugs mentioned

• CD19 CAR-T therapy (CD19-targeted CAR-T cell therapy)

Snippet

Sponsor: Zhejiang University | Conditions: Large B-Cell Lymphoma (LBCL) | Phase 2 | Status: RECRUITING